Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit

ABSTRACT Background and purpose: Tamoxifen remains an important adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Thus, determination of hormone receptors is important. Here, we compare cytosol-based methods, immunohistochemistry (IHC), and gene expression (...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Terese Engström, Maria Ekholm, Mårten Fernö, Christine Lundgren, Bo Nordenskjöld, Olle Stål, Pär-Ola Bendahl, Julia Tutzauer, Lisa Rydén
Format:	Artigo
Jezik:	Inglês
Izdano:	Medical Journals Sweden 2024-04-01
Serija:	Acta Oncologica
Teme:	breast cancer tamoxifen premenopausal patients randomized trial estrogen receptor status progesterone receptor status
Online dostop:	https://medicaljournalssweden.se/actaoncologica/article/view/19655
Oznake:	Označite Brez oznak, prvi označite!